Using diffusion MRI to tell spine lesions apart
Part of Blood & lymphatic clinical trials.
This study uses a special type of MRI (diffusion MRI) to look at abnormal areas in the spine and help tell them apart. It may help doctors better understand whether these areas are benign (non-cancerous) or something more serious.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 years or older).
- You must have a suspicious or confirmed lesion (abnormal area) in your spine, seen on X-ray or CT scan.
- You must not have any metal implants that are unsafe for MRI (like certain metal hip or knee replacements).
- You must not have had previous spine surgery.
- You must not have any birth defects of the spine.
- You must agree to have the MRI scan (and not have severe claustrophobia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new MRI technique called BoneMRI that may show bones more clearly than standard MRI. If you already need both a CT and an MRI of your spine, your scans could be used to compare this new method with the regular ones.
This study tests a new way to make MRI scans look like CT scans to find bone damage from multiple myeloma. You may join if you have just been diagnosed or if your disease came back after strong treatments, and you need bone imaging for staging.
This trial studies whether a special type of MRI can find brain white matter changes early. It might help people who have early symptoms or are at risk for diseases affecting the brain's wiring.
This study looks at MRI scans of the bone marrow to better understand various cancers and blood disorders. It may help improve how these conditions are diagnosed and treated.
This study tests new MRI scan settings to see inflammatory changes in the spinal cord more clearly. It may help doctors choose better MRI images when first checking—or re-checking—spinal inflammation.
This study is testing different ways to give MRI contrast dye to better see if cancer has spread to the lining of the brain (leptomeningeal disease). It's for people with solid tumors who have had unclear results on standard scans or who are at high risk but have negative tests.
Hear when a new Bone Marrow Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.